心因性瘙痒诊断与管理专家共识（2026版）

doi:10.35541/cjd.20260259

中华皮肤科杂志 ›› 2026, Vol. 59 ›› Issue (11): 1027-1035.doi: 10.35541/cjd.20260259

• 指南与共识·慢性皮肤瘙痒 • 上一篇下一篇

心因性瘙痒诊断与管理专家共识（2026版）

中华医学会心身医学分会心身皮肤病协作学组中国医师协会皮肤科医师分会中国康复医学会皮肤病康复专业委员会

中华医学会心身医学分会心身皮肤病协作学组中国医师协会皮肤科医师分会中国康复医学会皮肤病康复专业委员会

收稿日期:2026-05-11 修回日期:2026-10-06 发布日期:2026-11-03
通讯作者: 谢志强；张海萍；高兴华 E-mail:xiezq66@163.com; zhanghaiping@xwhosp.org; gaobarry@hotmail.com

Expert consensus on the diagnosis and management of psychogenic pruritus （2026 edition）

Psychodermatology Group, Chinese Society of Psychosomatic Medicine; China Dermatologist Association; Chinese Association of Rehabilitation Dermatology

Psychodermatology Group, Chinese Society of Psychosomatic Medicine; China Dermatologist Association; Chinese Association of Rehabilitation Dermatology

Received:2026-05-11 Revised:2026-10-06 Published:2026-11-03
Contact: Xie Zhiqiang; Zhang Haiping; Gao Xinghua E-mail:xiezq66@163.com; zhanghaiping@xwhosp.org; gaobarry@hotmail.com

摘要/Abstract

摘要： 【摘要】心因性瘙痒是指心理因素、精神因素以及心身因素在瘙痒的发生、加重或持续过程中起关键作用的一类瘙痒性疾病，严重影响患者及其家庭生活质量。心因性瘙痒临床并非少见，误诊误治现象较为普遍。为规范心因性瘙痒的管理，中华医学会心身医学分会心身皮肤病协作学组、中国医师协会皮肤科医师分会及中国康复医学会皮肤病康复专业委员会组织相关领域专家，在梳理国内外文献、总结专家临床经验的基础上，结合我国诊疗现状，制订了《心因性瘙痒诊断与管理专家共识（2026版）》。

关键词: 瘙痒症, 心因性瘙痒, 诊断, 治疗, 专家共识

Abstract: 【Abstract】 Psychogenic pruritus is a pruritic disorder in which psychological,mental,and psychosomatic factors play a critical role in the onset, aggravation, or persistence of the condition, substantially affecting the quality of life of patients and their families. Psychogenic pruritus is not rare in clinical practice, and misdiagnosis and mistreatment are relatively common. To standardize the management of psychogenic pruritus, the Psychodermatology Group of the Chinese Society of Psychosomatic Medicine, the China Dermatologist Association, and the Chinese Association of Rehabilitation Dermatology convened a panel of experts in relevant fields to develop the “Expert consensus on the diagnosis and management of psychogenic pruritus （2026 edition）”, based on Chinese and international literature, experts' clinical experience, and the current status of diagnosis and treatment of psychogenic pruritus in China.

Key words: Pruritus, Psychogenic pruritus, Diagnosis, Treatment, Expert consensus

中华医学会心身医学分会心身皮肤病协作学组中国医师协会皮肤科医师分会中国康复医学会皮肤病康复专业委员会 . 心因性瘙痒诊断与管理专家共识（2026版）[J]. 中华皮肤科杂志, 2026,59(11):1027-1035. doi:10.35541/cjd.20260259

Psychodermatology Group, Chinese Society of Psychosomatic Medicine, China Dermatologist Association, Chinese Association of Rehabilitation Dermatology. Expert consensus on the diagnosis and management of psychogenic pruritus （2026 edition）[J]. Chinese Journal of Dermatology, 2026, 59(11): 1027-1035.doi:10.35541/cjd.20260259

参考文献 69

［1］	Ständer S, Schmelz M, Lerner E, et al. A multidisciplinary Delphi consensus on the modern definition of pruritus: sensation and disease［J］. J Eur Acad Dermatol Venereol, 2026,40（1）:59⁃66. DOI: 10.1111/jdv.20851.
［2］	Ständer S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch［J］. Acta Derm Venereol, 2007,87（4）:291⁃294. DOI: 10.2340/00015555⁃0305.
［3］	中国康复医学会皮肤病康复专业委员会, 中国中西医结合学会皮肤性病专业委员会老年皮肤病学组. 老年皮肤瘙痒症诊疗与康复专家共识（2025版）［J］. 中华皮肤科杂志, 2025,58（1）:1⁃8. DOI: 10.35541/cjd.20240407.
［4］	Misery L, Alexandre S, Dutray S, et al. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French Psychodermatology Group［J］. Acta Derm Venereol, 2007, 87（4）: 341⁃344. DOI: 10.2340/00015555⁃0266.
［5］	Weisshaar E, Müller S, Szepietowski JC, et al. European S2k guideline on chronic pruritus［J］. Acta Derm Venereol, 2025,105:adv44220. DOI: 10.2340/actadv.v105.44220.
［6］	Mazeh D, Melamed Y, Cholostoy A, et al. Itching in the psychiatric ward［J］. Acta Derm Venereol, 2008,88（2）:128⁃131. DOI: 10.2340/00015555⁃0406.
［7］	Kretzmer GE, Gelkopf M, Kretzmer G, et al. Idiopathic pruritus in psychiatric inpatients: an explorative study［J］. Gen Hosp Psychiatry, 2008,30（4）:344⁃348. DOI: 10.1016/j.genhosppsych. 2008.03.006.
［8］	Kazmi A, Leslie T. Psychogenic pruritus［M］//Bewley A, Lepping P, Taylor R. Psychodermatology in clinical practice. Cham: Springer, 2021:303⁃315. DOI: 10.1007/978⁃3⁃030⁃54307⁃5_23.
［9］	中国医师协会皮肤科医师分会. 慢性瘙痒管理指南（2024版）［J］. 中华皮肤科杂志, 2024,57（5）:387⁃399. DOI: 10. 35541/cjd.20230746.
［10］	谢志强, 傅君舟, 陈敢, 等. 改良川岛瘙痒严重度评价方法与视觉模拟评分法的相关性［J］. 中国医学科学院学报, 2018,40（4）:539⁃542. DOI: 10.3881/j.issn.1000⁃503X.10320.
［11］	Zeidler C, Pereira MP, Augustin M, et al. Investigator's global assessment of chronic prurigo: a new instrument for use in clinical trials［J］. Acta Derm Venereol, 2021,101（2）:adv00401. DOI: 10.2340/00015555⁃3701.
［12］	Bewley A, Taylor RE, Reichenberg JS, et al. 实用精神皮肤病学［M］. 谢志强, 岳伟华, 译. 北京: 北京大学医学出版社, 2017: 281⁃296.
［13］	Tong X, An D, McGonigal A, et al. Validation of the Generalized Anxiety Disorder⁃7 （GAD⁃7） among Chinese people with epilepsy［J］. Epilepsy Res, 2016,120:31⁃36. DOI: 10.1016/j.eplepsyres.2015.11.019.
［14］	Leung DY, Lam TH, Chan SS. Three versions of Perceived Stress Scale: validation in a sample of Chinese cardiac patients who smoke［J］. BMC Public Health, 2010,10:513. DOI: 10.1186/1471⁃2458⁃10⁃513.
［15］	Leising D, Grande T, Faber R. The Toronto Alexithymia Scale （TAS⁃20）: a measure of general psychological distress［J］. J Res Pers, 2009, 43（4）: 707⁃710. DOI: 10.1016/j.jrp.2009.03.009.
［16］	Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research［J］. Sleep Med, 2001,2（4）:297⁃307. DOI: 10.1016/s1389⁃9457（00）00065⁃4.
［17］	Verhoeven EW, de Klerk S, Kraaimaat FW, et al. Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review［J］. Acta Derm Venereol, 2008,88（3）:211⁃218. DOI: 10.2340/00015555⁃0452.
［18］	Ferreira BR, Katamanin OM, Jafferany M, et al. Psychodermatology of chronic pruritus: an overview of the link between itch and distress［J］. Dermatol Ther （Heidelb）, 2024,14（7）:1799⁃1809. DOI: 10.1007/s13555⁃024⁃01214⁃z.
［19］	Zhang H, Wang M, Zhao X, et al. Role of stress in skin diseases: a neuroendocrine⁃immune interaction view［J］. Brain Behav Immun, 2024, 116: 286⁃302. DOI: 10.1016/j.bbi.2023.12.005.
［20］	Herman JP, Figueiredo H, Mueller NK, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo⁃pituitary⁃adrenocortical responsiveness［J］. Front Neuroendocrinol, 2003,24（3）:151⁃180. DOI: 10. 1016/j.yfrne.2003.07.001.
［21］	Kim JE, Cho BK, Cho DH, et al. Expression of hypothalamic⁃pituitary⁃adrenal axis in common skin diseases: evidence of its association with stress⁃related disease activity［J］. Acta Derm Venereol, 2013,93（4）:387⁃393. DOI: 10.2340/00015555⁃1557.
［22］	Golpanian RS, Kim HS, Yosipovitch G. Effects of stress on itch［J］. Clin Ther, 2020,42（5）:745⁃756. DOI: 10.1016/j.clinthera. 2020.01.025.
［23］	Arck P, Paus R. From the brain⁃skin connection: the neuroendocrine⁃immune misalliance of stress and itch［J］. Neuroimmunomodulation, 2006,13（5⁃6）:347⁃356. DOI: 10. 1159/000104863.
［24］	Aberg KM, Radek KA, Choi EH, et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice［J］. J Clin Invest, 2007,117（11）:3339⁃3349. DOI: 10.1172/JCI31726.
［25］	Gonzalez T, Bilik SM, Burke OM, et al. Host⁃microbiome interactions in chronic itch［J］. J Clin Med, 2025, 14（16）: 5633. DOI: 10.3390/jcm14165633.
［26］	Coccurello R. The skin microbiome and affective symptoms: neuroimmune, neuroendocrine, and sensory pathways linking inflammatory dermatoses to mood and anxiety burden［J］. Front Neuroendocrinol, 2026,81:101251. DOI: 10.1016/j.yfrne.2026. 101251.
［27］	Elenkov IJ. Glucocorticoids and the Th1/Th2 balance［J］. Ann N Y Acad Sci, 2004, 1024: 138⁃146. DOI: 10.1196/annals.1321. 010.
［28］	Khalil NB, Coscarella G, Dhabhar FS, et al. A narrative review on stress and itch: what we know and what we would like to know［J］. J Clin Med, 2024, 13（22）: 6854. DOI: 10.3390/jcm13226854.
［29］	Heijnen CJ. Receptor regulation in neuroendocrine⁃immune communication: current knowledge and future perspectives［J］. Brain Behav Immun, 2007,21（1）:1⁃8. DOI: 10.1016/j.bbi. 2006.08.008.
［30］	Ulrich⁃Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses［J］. Nat Rev Neurosci, 2009,10（6）:397⁃409. DOI: 10.1038/nrn2647.
［31］	Nakagawa Y, Yamada S. Alterations in brain neural network and stress system in atopic dermatitis: novel therapeutic interventions［J］. J Pharmacol Exp Ther, 2023,385（2）:78⁃87. DOI: 10.1124/jpet.122.001482.
［32］	Pavlenko D, Akiyama T. Why does stress aggravate itch? A possible role of the amygdala［J］. Exp Dermatol, 2019,28（12）:1439⁃1441. DOI: 10.1111/exd.13941.
［33］	McConnell I, Davis JM, Mishra SK. Comorbid depression in atopic dermatitis⁃the itch⁃to⁃brain circuitry theory［J］. JAMA Psychiatry, 2026,83（5）:435⁃436. DOI: 10.1001/jamapsychiatry. 2026.0029.
［34］	Tian J, Cao Y, Li Y, et al. A sympathetic⁃eosinophil axis orchestrates psychological stress to exacerbate skin inflammation［J］. Science, 2026,391（6791）:1269⁃1277. DOI: 10.1126/science. adv5974.
［35］	Xie X, Jiang W, Lun L, et al. Hyperactivation of sympathetic nerves fuels basophil infiltration in atopic dermatitis［J］. Immunity, 2026,59（3）:598⁃617. DOI: 10.1016/j.immuni. 2026. 01.010.
［36］	Scott⁃Solomon E, Brielle S, Mann AO, et al. Stress⁃induced sympathetic hyperactivation drives hair follicle necrosis to trigger autoimmunity［J］. Cell, 2026,189（1）:252⁃271. DOI: 10. 1016/j.cell.2025.10.042.
［37］	Huang L, Kang P, Chen J, et al. Sympathetic nerve aggravates autoimmune skin disease via NE⁃adrenergic receptor axis: neuroimmune cross⁃talk insights from vitiligo［J］. Sci Adv, 2026,12（10）:eaea7017. DOI: 10.1126/sciadv.aea7017.
［38］	Qu L, Fu K, Yang J, et al. CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis［J］. Pain, 2015,156（9）:1737⁃1746. DOI: 10.1097/j.pain.00000000 00000208.
［39］	Yu S, Xu Y, Li Y, et al. Sympathetic nerve dysfunction exacerbates skin inflammation in atopic dermatitis［J］. J Allergy Clin Immunol, 2026,157（3）:677⁃692. DOI: 10.1016/j.jaci.2025. 12.994.
［40］	Kim HS, Yosipovitch G. An aberrant parasympathetic response: a new perspective linking chronic stress and itch［J］. Exp Dermatol, 2013,22（4）:239⁃244. DOI: 10.1111/exd.12070.
［41］	Welcome MO. Cellular mechanisms and molecular signaling pathways in stress⁃induced anxiety, depression, and blood⁃brain barrier inflammation and leakage［J］. Inflammopharmacology, 2020,28（3）:643⁃665. DOI: 10.1007/s10787⁃020⁃00712⁃8.
［42］	Zhang Z, Li H, Yang J, et al. Interleukin⁃17 plays a crucial role in atopic dermatitis⁃associated blood⁃brain barrier disruption and cognitive impairment［J］. Brain Behav Immun, 2026,136: 106564. DOI: 10.1016/j.bbi.2026.106564.
［43］	Montague⁃Cardoso K, Malcangio M. Changes in blood⁃spinal cord barrier permeability and neuroimmune interactions in the underlying mechanisms of chronic pain［J］. Pain Rep, 2021,6（1）:e879. DOI: 10.1097/PR9.0000000000000879.
［44］	Hermans D, Houben E, Baeten P, et al. Oncostatin M triggers brain inflammation by compromising blood⁃brain barrier integrity［J］. Acta Neuropathol, 2022,144（2）:259⁃281. DOI: 10.1007/s00401⁃022⁃02445⁃0.
［45］	Sarapultsev A, Gusev E, Komelkova M, et al. JAK⁃STAT signaling in inflammation and stress⁃related diseases: implications for therapeutic interventions［J］. Mol Biomed, 2023,4（1）:40. DOI: 10.1186/s43556⁃023⁃00151⁃1.
［46］	Lee J, Wheeler MA. Immune⁃brain plasticity underpins stress and affective behaviors［J］. Neuron, 2026,114（1）:9⁃32. DOI: 10.1016/j.neuron.2025.11.020.
［47］	Biazus Soares G, Mahmoud O, Yosipovitch G, et al. The mind⁃skin connection: a narrative review exploring the link between inflammatory skin diseases and psychological stress［J］. J Eur Acad Dermatol Venereol, 2024,38（5）:821⁃834. DOI: 10.1111/jdv.19813.
［48］	Zeidler C, Kupfer J, Dalgard FJ, et al. Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: results from a European multi⁃centre study［J］. J Eur Acad Dermatol Venereol, 2024,38（8）:1649⁃1661. DOI: 10.1111/jdv.19913.
［49］	Ishiuji Y. Addiction and the itch⁃scratch cycle: what do they have in common?［J］. Exp Dermatol, 2019,28（12）:1448⁃1454. DOI: 10.1111/exd.14029.
［50］	Hania A, Jamil S, Jamil S. How psychological distress translates into psychogenic pruritus: alexithymia, body awareness, and coping in a Pakistani collectivistic sample［J］. J Psychosom Res, 2026,205:112607. DOI: 10.1016/j.jpsychores.2026.112607.
［51］	Ferreira BR, Misery L. Alexithymia and dissociation in psychogenic pruritus: clinical relevance and therapeutic implications［J］. J Eur Acad Dermatol Venereol, 2024,38（9）: e813⁃e815. DOI: 10.1111/jdv.19918.
［52］	Faria M, Ganz A, Galkin F, et al. Psychogenic aging: a novel prospect to integrate psychobiological hallmarks of aging［J］. Transl Psychiatry, 2024,14（1）:226. DOI: 10.1038/s41398⁃024⁃02919⁃7.
［53］	Orliaguet M, Brenaut E, Ficheux AS, et al. Psychogenic and neurogenic components in patients with psychogenic or neuropathic pruritus: PRURINEURO: a non⁃interventional single⁃centre prospective assay［J］. Skin Health Dis, 2023,3（6）:e267. DOI: 10.1002/ski2.267.
［54］	Patel A, Jafferany M. Multidisciplinary and holistic models of care for patients with dermatologic disease and psychosocial comorbidity: a systematic review［J］. JAMA Dermatol, 2020,156（6）:686⁃694. DOI: 10.1001/jamadermatol.2020.0394.
［55］	Buteau A, Reichenberg J. Psychogenic pruritus and its management［J］. Dermatol Clin, 2018,36（3）:309⁃314. DOI: 10.1016/j.det.2018.02.015.
［56］	Schuch FB, Vancampfort D, Richards J, et al. Exercise as a treatment for depression: a meta⁃analysis adjusting for publication bias［J］. J Psychiatr Res, 2016,77:42⁃51. DOI: 10.1016/j.jpsychires.2016.02.023.
［57］	Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress⁃related disorders: a meta⁃analysis［J］. Psychiatry Res, 2017,249:102⁃108. DOI: 10.1016/j.psychres.2016.12.020.
［58］	Ju Y, Pei H, Kang N, et al. Prevalence and potential risk factors of chronic pruritus among community middle⁃aged and older population in Beijing, China［J］. J Eur Acad Dermatol Venereol, 2022,36（7）:1074⁃1079. DOI: 10.1111/jdv.18041.
［59］	Ghani H, Ghofrani S, Modanlo N, et al. Novel and existing therapeutic interventions in psychogenic pruritus［J］. Clin Exp Dermatol, 2026,51（6）:951⁃957. DOI: 10.1093/ced/llag005.
［60］	Demirbas A, Diremsizoglu E, Esen M, et al. Comparative effectiveness and safety of upadacitinib, abrocitinib and dupilumab in treatment⁃resistant prurigo nodularis［J］. Clin Exp Dermatol, 2026,51（4）:587⁃595. DOI: 10.1093/ced/llaf518.
［61］	Vahabi SM, Heidari S, Pourgholi E, et al. Janus kinase inhibitors for the treatment of prurigo nodularis: a systematic review of 211 patients［J］. J Dermatol, 2026,53（4）:556⁃577. DOI: 10.1111/1346⁃8138.70150.
［62］	Shafiyev J, Gahramanov I. Evaluating duloxetine for pruritus and psychiatric comorbidities in lichen simplex chronicus［J］. Arch Dermatol Res, 2025,317（1）:249. DOI: 10.1007/s00403⁃024⁃03775⁃7.
［63］	Kwatra SG, Bordeaux ZA, Parthasarathy V, et al. Efficacy and safety of abrocitinib in prurigo nodularis and chronic pruritus of unknown origin: a nonrandomized controlled trial［J］. JAMA Dermatol, 2024,160（7）:717⁃724. DOI: 10.1001/jamadermatol. 2024.1464.
［64］	Ghani H, Ghofrani S, Jafferany M. Therapeutic challenges and novel treatment options in psychogenic pruritus［J］. Arch Dermatol Res, 2024,317（1）:121. DOI: 10.1007/s00403⁃024⁃03644⁃3.
［65］	Ho CY, Wu HL, Dai YX, et al. Association of Janus kinase inhibitors with reduced depression in alopecia areata［J］. J Eur Acad Dermatol Venereol, 2026,40（8）:1382⁃1391. DOI: 10. 1111/jdv.70184.
［66］	Nettis E, Cristallo M, Fiorella CS, et al. Upadacitinib is efficacious in reducing the alexithymic trait in adult patients with moderate⁃to⁃severe atopic dermatitis: a prospective multicenter real⁃life study［J］. Ital J Dermatol Venerol, 2025,160（5）:398⁃405. DOI: 10.23736/S2784⁃8671.25.08228⁃3.
［67］	Frankel D, Ma E, Gage D, et al. Cross⁃sectional analysis of mental health comorbidities in patients with prurigo nodularis［J］. J Am Acad Dermatol, 2025, 93（1）: 270⁃272. DOI: 10.1016/j.jaad.2025.03.015.
［68］	Ständer S, Elmariah SB, Kwatra SG, et al. Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies［J］. J Eur Acad Dermatol Venereol, 2026,40（5）:867⁃875. DOI: 10.1111/jdv.70250.
［69］	Gruzmark FS, Yosipovitch G, Lev⁃Tov HA. Resolution of lichen simplex chronicus with nemolizumab: a case report［J］. J Drugs Dermatol, 2025,24（12）:1252⁃1253. DOI: 10.36849/JDD.9273.

[1]	梁云生. [开放获取] 慢性手部湿疹评估现状及进展[J]. 中华皮肤科杂志, 2026, 59(9): 850-855.
[2]	唐祯刘宇航杨凌胡凌雪贺治杰曹凯丁澍. 反射式共聚焦显微镜在皮肤型红斑狼疮诊断与鉴别诊断中的价值及特征分析[J]. 中华皮肤科杂志, 2026, 59(9): 873-880.
[3]	中国医师协会皮肤科医师分会中华医学会皮肤性病学分会中国医疗保健国际交流促进会皮肤医学分会中国罕见病联盟皮肤病学分会 . [开放获取] 斑块状银屑病生物制剂长程治疗管理专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(9): 827-843.
[4]	《西罗莫司治疗卡波西样血管内皮瘤中国专家共识（版）》制订专家组. 西罗莫司治疗卡波西样血管内皮瘤中国专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(8): 728-737.
[5]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. 中国皮肤鳞状细胞癌诊疗指南（2026版）[J]. 中华皮肤科杂志, 2026, 59(8): 703-716.
[6]	《脓疱型银屑病诊疗中国专家共识（版）》编写委员会专家组. [开放获取] 脓疱型银屑病诊疗中国专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(8): 717-727.
[7]	李燕红姜琨吴卓璇章建兰方美珍刘姝婷王琳琳胡磊周小勇陈柳青陈金波. 程序性死亡受体1抑制剂相关皮肤不良反应18例临床资料分析[J]. 中华皮肤科杂志, 2026, 59(8): 783-787.
[8]	魏瑾闫会文张建中伦文辉. 司库奇尤单抗治疗合并人类免疫缺陷病毒感染的中重度斑块状银屑病10例临床疗效观察[J]. 中华皮肤科杂志, 2026, 59(7): 671-674.
[9]	王琳琳曹立娟陈柳青李东升胡燕燕. 海姆泊芬光动力疗法治疗四肢鲜红斑痣疗效观察及安全性回顾分析[J]. 中华皮肤科杂志, 2026, 59(7): 637-644.
[10]	刘怿菲金炫沃刘鹏月张希萌吴严. 点阵CO2激光联合A型肉毒毒素外用治疗面部毛孔粗大的半脸自身对照临床试验[J]. 中华皮肤科杂志, 2026, 59(7): 645-653.
[11]	张国龙赵子君. 氨基酮戊酸光动力疗法治疗皮肤鳞状细胞癌的现状、挑战和思考[J]. 中华皮肤科杂志, 2026, 59(7): 626-631.
[12]	中国研究型医院学会皮肤科学专业委员会中国医师协会皮肤科医师分会. [开放获取] 窄谱中波紫外线光疗皮肤科临床应用指南（2026版）[J]. 中华皮肤科杂志, 2026, 59(7): 595-610.
[13]	中华医学会皮肤性病学分会光动力治疗研究协作组中国康复医学会皮肤病康复专业委员会及光动力治疗与康复专业委员会中国医学装备协会皮肤病与皮肤美容分会光医学治疗装备学组. 氨基酮戊酸光动力疗法治疗尖锐湿疣的临床应用指南（2026版）[J]. 中华皮肤科杂志, 2026, 59(7): 611-618.
[14]	何庆张涛王秀丽高兴华陈洪铎柳敏齐瑞群. 光线性角化病恶性进展相关生物标志物的研究进展[J]. 中华皮肤科杂志, 2026, 59(7): 687-690.
[15]	中华医学会皮肤性病学分会儿童皮肤病学组中华医学会儿科学分会皮肤病学组中国康复医学会皮肤病康复专业委员会儿童学组中国康复医学会皮肤病康复专业委员会特应性皮炎学组中国医师协会皮肤科医师分会儿童皮肤病学组中国医师协会儿科学分会皮肤病学组. [开放获取] 中国儿童特应性皮炎预防、治疗与管理实践共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(6): 487-504.

心因性瘙痒诊断与管理专家共识（2026版）

Expert consensus on the diagnosis and management of psychogenic pruritus （2026 edition）

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 69

相关文章 15

Metrics

本文评价

推荐阅读 2